ATP6V1A
V-type proton ATPase catalytic subunit A
Also known as: ATP6A1, ATP6V1A1, VA68, VATA_HUMAN, Vma1, VPP2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P38606
- Gene
- ATP6V1A
- Ensembl
- ENSG00000114573
- Chromosome
- 3
- Canonical length
- 617 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
OverviewNCBI Gene
This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A and three B subunits, two G subunits plus the C, D, E, F, and H subunits. The V1 domain contains the ATP catalytic site. The V0 domain consists of five different subunits: a, c, c', c"""""""""""""""""""""""""""""""", and d. Additional isoforms of many of the V1 and V0 subunit proteins are encoded by multiple genes or alternatively spliced transcript variants. This encoded protein is one of two V1 domain A subunit isoforms and is found in all tissues. Transcript variants derived from alternative polyadenylation exist. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
617 residues, UniProt reviewed canonical sequence.
>P38606|ATP6V1A
1 MDFSKLPKIL DEDKESTFGY VHGVSGPVVT ACDMAGAAMY ELVRVGHSEL VGEIIRLEGD
61 MATIQVYEET SGVSVGDPVL RTGKPLSVEL GPGIMGAIFD GIQRPLSDIS SQTQSIYIPR
121 GVNVSALSRD IKWDFTPCKN LRVGSHITGG DIYGIVSENS LIKHKIMLPP RNRGTVTYIA
181 PPGNYDTSDV VLELEFEGVK EKFTMVQVWP VRQVRPVTEK LPANHPLLTG QRVLDALFPC
241 VQGGTTAIPG AFGCGKTVIS QSLSKYSNSD VIIYVGCGER GNEMSEVLRD FPELTMEVDG
301 KVESIMKRTA LVANTSNMPV AAREASIYTG ITLSEYFRDM GYHVSMMADS TSRWAEALRE
361 ISGRLAEMPA DSGYPAYLGA RLASFYERAG RVKCLGNPER EGSVSIVGAV SPPGGDFSDP
421 VTSATLGIVQ VFWGLDKKLA QRKHFPSVNW LISYSKYMRA LDEYYDKHFT EFVPLRTKAK
481 EILQEEEDLA EIVQLVGKAS LAETDKITLE VAKLIKDDFL QQNGYTPYDR FCPFYKTVGM
541 LSNMIAFYDM ARRAVETTAQ SDNKITWSII REHMGDILYK LSSMKFKDPL KDGEAKIKSD
601 YAQLLEDMQN AFRSLEDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ATP6V1A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.23
- Highest tissue expression
- 87 nTPM
Expression across tissuesHPA
Tissue
- kidney: 87 nTPM
- cerebral cortex: 86 nTPM
- parathyroid gland: 56 nTPM
- retina: 55 nTPM
- hypothalamus: 52 nTPM
- choroid plexus: 51 nTPM
Single-cell type
- late spermatids: 1,352 nCPM
- early spermatids: 759 nCPM
- neutrophils: 680 nCPM
- respiratory ionocytes: 612 nCPM
- epididymal clear cells: 517 nCPM
- salivary ionocytes: 488 nCPM
Immune cell
- neutrophil: 79 nTPM
- myeloid DC: 36 nTPM
- classical monocyte: 35 nTPM
- basophil: 30 nTPM
- intermediate monocyte: 26 nTPM
- non-classical monocyte: 23 nTPM
Brain region
- choroid plexus: 198 nTPM
- hypothalamus: 180 nTPM
- cerebral cortex: 180 nTPM
- basal ganglia: 159 nTPM
- pons: 153 nTPM
- hippocampal formation: 143 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ATP6V1A.
Disease | AllUniProt
Conditions ATP6V1A is implicated in, by any mechanism.
- Cutis laxa, autosomal recessive, 2D (ARCL2D) MIM:617403
- Epileptic encephalopathy, infantile or early childhood, 3 (IECEE3) MIM:618012
Disease | GeneticClinVar
26 pathogenic / likely-pathogenic of 455 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Developmental and epileptic encephalopathy 93
- Autosomal recessive cutis laxa type 2D
- Inborn genetic diseases
- Cerebral visual impairment and intellectual disability
- Encephalopathy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.36
- gnomAD pLI
- 0.87
- gnomAD missense Z
- 3.37
- DepMap mean gene effect
- -1.91
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- ATP metabolic process
- cellular response to increased oxygen levels
- endosomal lumen acidification
- Golgi lumen acidification
- intracellular iron ion homeostasis
- intracellular pH reduction
- lysosomal lumen acidification
- proton transmembrane transport
- regulation of macroautophagy
- synaptic vesicle lumen acidification
- vacuolar acidification
Molecular functions
Cellular components
- apical plasma membrane
- clathrin-coated vesicle membrane
- cytosol
- endosome membrane
- extracellular exosome
- extrinsic component of synaptic vesicle membrane
- Golgi membrane
- lysosomal membrane
- membrane
- microvillus
- nucleoplasm
- plasma membrane
- proton-transporting two-sector ATPase complex
- proton-transporting V-type ATPase complex
- secretory granule
- vacuolar proton-transporting V-type ATPase, V1 domain
Protein domainsUniProt · Pfam · InterPro
- ATPase, F1/V1/A1 complex, alpha/beta subunit, nucleotide-binding domain
- ATPase, F1/V1/A1 complex, alpha/beta subunit, N-terminal domain
- ATPase, alpha/beta subunit, nucleotide-binding domain, active site
- ATP synthase subunit alpha, N-terminal domain-like superfamily
- ATPase, F1/V1 complex, beta/alpha subunit, C-terminal
- P-loop containing nucleoside triphosphate hydrolase
- ATPase, F1/V1/A1 complex, alpha/beta subunit, N-terminal domain superfamily
- ATP synthase A/B type, C-terminal domain
- ATP synthase alpha/beta family, nucleotide-binding domain
- ATP synthase alpha/beta family, beta-barrel domain
- C-terminal domain of V and A type ATP synthase
- ATPase, V1 complex, subunit A
- V-type ATP synthase catalytic alpha chain
- ATPsynthase alpha/beta subunit, barrel-sandwich domain
- ATPsynthase alpha/beta subunit barrel-sandwich domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ATP6V1A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ATP6V1A as an antibody target. Whether an autoantibody or antibody against ATP6V1A could matter depends on whether native ATP6V1A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ATP6V1A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ATP6V1A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...